7th Drug Formulation, Solubility and Bioavailability

Conference themes
When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation and delivery strategies to maximize bioavailability. ExL's 7th Drug Formulation, Solubility and Bioavailability conference helps you recognize the precise thresholds where an enabled formulation becomes necessary, as well as determine which method to use and how to predict and gauge its success.

Professional congress organizer (PCO)
Exl Events

Notes
Speakers: Rossitza Alargova Director, Formulations, INFINITY PHARMACEUTICALS, Gail Dempsey EOC and Director, Manufacturing Technologies, PIEDMONT ANIMAL HEALTH, Rakesh Dixit Vice President, RandD, Global Head, Biologics Safety, MEDIMMUNE

URLs: Brochure: https://go.evvnt.com/174423-1 Booking: https://go.evvnt.com/174423-2

Ms. Alysha Parker